Skip to main content
Tulane Home Tulane Home

Tulane Cancer Center ~ Clinical Trials ~ Bladder

BMS-274
A Phase 3 Randomized, Double-Blind, Multi-Center Study of Adjuvant Nivolumab versus Placebo in Subjects with High-Risk Invasive Urothelial Carcinoma (CA209-274).
More Information